Ignite Creation Date:
2025-12-25 @ 4:20 AM
Ignite Modification Date:
2026-02-26 @ 12:21 AM
Study NCT ID:
NCT00317720
Status:
COMPLETED
Last Update Posted:
2025-04-30
First Post:
2006-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-21
First Submit QC Date:
None
Study First Post Date:
2006-04-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-30
Results First Submit QC Date:
None
Results First Post Date:
2014-06-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-24
Last Update Post Date:
2025-04-30
Last Update Post Date Type:
ACTUAL